Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Survey of sleep quality and associated factors.
- Who it may be relevant to
- Registry conditions: Cancer Survivors. Basic parameters: 15 years — 24 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Medical professionals now take into account the specificities of the care and support of Adolescents and Young Adults (AYAs). Cancer aftermaths in patients diagnosed during the AYA period are also known: the consequences of chemotherapy and radiotherapy treatments on a growing organism, the difficulty of some follow-ups, the longevity, and the delayed occurrence of certain complications. In the general population, sleep disorders affect 40% of adolescents. About 30% of pediatric cancer survivors experience fatigue they attribute to their cancer, even years after the end of their treatment. The sleep quality of patients treated for cancer when they were AYAs, and the eventual care of sleeping disorders, are poorly studied. The investigators suppose that the oncologic treatment during this particular life stage, when sleeping disorders are already present and multifactorial, could have long-term impacts on sleep. The investigators offer to evaluate, through a questionnaire filled out by patients treated for cancer in the AYA period, the frequency of moderate to severe insomnia.
Interventions
- Other Survey of sleep quality and associated factors
Sleep quality and associated factors (anxiety, depression, and pain) will be evaluated through an online survey on the Reseau Morphee platform, through an self-administered evaluation of the patients' pain and sleep difficulties, and a precarity scale.
Primary outcome measures
- Number of patients presenting moderate or severe insomnia [Time frame: Day 1]
Secondary outcome measures (1)
- Identification of sleep disorders risk factors [Time frame: Day 1]
Eligibility criteria
Inclusion criteria
- Patient treated for a cancer
- Patient aged between 15 and 24 years old at the time of the diagnosis
- Patients whom intensive treatment ended at least 3 months ago
- Patient followed in a PACAAURA cancerology center
- Life expectancy ≥ 6 months
- Karnosky index > 60%
- Patient who agrees to participate in the program and benefits from social security
- Patient able to understand, speak and read French.
- No major cognitive impairment (assessed by the patient's referees)
- No sensory disability
Exclusion criteria
- Patient unable to use informatic tools
- Known superior cognitive function disorders
- Progressive psychiatric pathology
- Drug user or alcohol abuse
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Screening
Study locations
France · 1 center
- CHU de Nice — Nice
Identifiers
NCT: NCT06904495 · 25-PP-02